The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
Services
Subscribe
Advertise
Rights & permissions
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Contact us
Author centre
Freek Verheugt
Showing 1-7 of 7 articles
Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trial
Serruys PW,
Tomaniak M,
Chichareon P,
Modolo R,
Kogame N,
Takahashi K,
Chang C,
Spitzer E,
Walsh S,
Adlam D,
Hildick-Smith D,
Édes I,
van de Harst P,
Krackhardt F,
Tijssen J,
Rademaker-Havinga T,
Garg S,
Steg G,
Hamm C,
Jüni P,
Vranckx P,
Onuma Y,
Verheugt F
December 20, 2019 | 10.4244/EIJ-D-19-00202
Bivalirudin in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: uncertainties almost clarified
Huber K,
Verheugt F
March 20, 2017 | 10.4244/EIJV12I16A315
Uninterrupted oral anticoagulation versus bridging in patients with long-term oral anticoagulation during percutaneous coronary intervention: subgroup analysis from the WOEST trial
Dewilde W,
Janssen P,
Kelder J,
Verheugt F,
de Smet B,
Adriaenssens T,
Vrolix M,
Brueren G,
Vandendriessche T,
van Mieghem C,
Cornelis K,
Vos J,
Breet N,
ten Berg JM
August 20, 2015 | 10.4244/EIJY14M06_07
A randomised study of dabigatran in elective percutaneous coronary intervention in stable coronary artery disease patients
Vranckx P,
Verheugt F,
de Maat MP,
Ulmans V,
Regar E,
Smits PC,
ten Berg JM,
Lindeboom W,
Jones R,
Friedman J,
Reilly P,
Leebeek F
January 18, 2013 | 10.4244/EIJV8I9A162
Bivalirudin versus unfractionated heparin in percutaneous coronary interventions of patients having received initial fondaparinux treatment: a propensity matched study
Hamon M,
Rao SV,
Steg G,
Valgimigli M,
Verheugt F,
Marso S,
Gershlick A,
Wang Y,
Deliargyris E
August 24, 2012 | 10.4244/EIJV8I4A76
Triggering mechanisms of stent thrombosis
Zwart B,
van Werkum J,
Heestermans A,
Kelder J,
Zomer A,
van 't Hof A,
Verheugt F,
ten Berg JM
January 20, 2011
Effect of PCI on inflammatory markers, adiponectin and insulin resistance
Gomes M,
Smits P,
Verheugt F,
Tack C
February 25, 2010
1
Latest news
AHEAD OF PRINT
Atherectomy in patients with lower extremity PAD
FREE ARTICLE - Mazen S. Albaghdadi et al
September 25, 2023
AHEAD OF PRINT
De-escalation from ticagrelor to clopidogrel in HBR patients
FREE ARTICLE - Min Chul Kim et al
September 19, 2023
NEW ISSUE
State-of-the-Art on Cerebral Embolic Protection; Debating Guided DAPT; 3-Year Outcomes of the EuroCTO Trial; the Myval Device in Non-Calcified Aortic Regurgitation...
New Issue
September 18, 2023
AHEAD OF PRINT
OCT guidance for evaluation and treatment of the long-term consequences of inadequate ostial left circumflex stenting
Free ARTICLE - Dejan Milasinovic et al
September 7, 2023
AHEAD OF PRINT
DCB in large coronary arteries
FREE ARTICLE - Pier Pasquale Leone et al
September 5, 2023
AHEAD OF PRINT
Rationale and design of the DEDICATE-DZHK6 Trial
FREE ARTICLE - Moritz Seiffert et al
September 1, 2023
AHEAD OF PRINT
DWP for TMVR
FREE ARTICLE - Clément Servoz et al
August 29, 2023